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The actin-myosin cytoskeleton is generally accepted to pro-
duce the contractile forces necessary for cellular processes such
as cell rounding andmigration.All vertebrates examined to date
are known to express at least two isoforms of non-muscle myo-
sin II, referred to as myosin IIA andmyosin IIB. Studies of myo-
sin IIA and IIB in cultured cells and null mice suggest that these
isoformsperformdistinct functions.However, howeachmyosin
II isoform contributes individually to all the cellular functions
attributed to “myosin II” has yet to be fully characterized. Using
isoform-specific small-interfering RNAs, we found that deple-
tion of either isoform resulted in opposing migration pheno-
types, withmyosin IIA- and IIB-depleted cells exhibiting higher
and lower wound healing migration rates, respectively. In addi-
tion, myosin IIA-depleted cells demonstrated impaired throm-
bin-induced cell rounding and undertook a more motile mor-
phology, exhibiting decreased amounts of stress fibers and focal
adhesions, with concomitant increases in cellular protrusions.
Cells depleted of myosin IIB, however, were efficient in throm-
bin-induced cell rounding, displayed a more retractile pheno-
type, and maintained focal adhesions but only in the periphery.
Last, we present evidence that Rho kinase preferentially regu-
lates phosphorylation of the regulatory light chain associated
with myosin IIA. Our data suggest that the myosin IIA and IIB
isoforms are regulated by different signaling pathways to per-
form distinct cellular activities and that myosin IIA is preferen-
tially required for Rho-mediated contractile functions.
Nonmuscle myosin II (henceforth, myosin II) is a ubiquitous
molecular motor that binds and contracts filamentous actin
(F-actin) in an ATP-dependent manner (1, 2). The forces that
are generated by contraction of the actin-myosin cytoskeleton
contribute to a diverse array of cellular processes in a variety of
cell types, including cytokinesis (3), platelet activation (4), cell
rounding (5), and cell migration (6, 7). The latter is a highly
complex process inwhich cells can participate either as isolated
individuals, such as neuroblast migration during development
or tumor cell metastasis, or as groups, as exemplified by the
coordinated movement of epithelial sheets during dorsal clo-
sure or wound healing.
The process of cell migration is often described as a cycle of
coordinated steps (8, 9) in which the first step is protrusion of
themembrane in the intended direction of movement followed
by stabilization of the extendedmembrane via the formation of
new adhesion sites. Last, the cell undergoes contraction, in
which the cell body translocates forward accompanied by tail
detachment and retraction. Although myosin II is thought to
perform multiple functions during the migration cycle, one
aspect of cell migration for which a clear requirement for myo-
sin II-based contractility has been demonstrated is the regula-
tion of focal adhesions. Focal adhesions are integrin-based,
large multimolecular assemblies that form a structural bridge
between the substrate and the actin cytoskeleton (10). Efficient
migration requires the proper coordination of adhesion assem-
bly in the front and de-adhesion in the rear (11), and myosin II
shares an intimate relationship with focal adhesions as their
assembly, maturation, and dynamics (12–14) depend on myo-
sin II-induced tension.
Much of the work describing the importance of myosin II in
cell motility has been performed using the genetically tractable
model systemsDictyostelium (7, 15) andDrosophila (16–18). It
is important to note, however, that Drosophila and Dictyoste-
lium harbor only a single myosin II molecule, whereas verte-
brates are known to express three distinct myosin IIs, referred
to as myosin IIA, IIB, and IIC (1, 19, 20). Myosin II is a hexam-
eric molecule comprised of a pair of heavy chains, a pair of
essential light chains, and a pair of regulatory light chains
(RLCs)4 (2). The distinction between the three myosin II mol-
ecules is based upon their unique heavy chain isoforms. Inter-
estingly, each isoform performs the same basic molecular
function, which is the binding and contraction of F-actin in an
ATP-dependent manner, and the activities of all three are
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thought to be regulated in a similar fashion; that is, through
phosphorylation of the RLC (2). Thus, how each myosin II iso-
form performs different cellular functions in vivo is not under-
stood. In this study we identified distinct functions of myosin
IIA and IIB (hereafter IIA and IIB, respectively) in epithelial cell
sheet migration and thrombin-induced cell rounding. Our data
demonstrate that these isoforms are differentially required for
cell rounding, and each isoform uniquely contributes to the
proper regulation of protrusions and adhesions and, thus,
propermigration. Furthermore, we demonstrate that phospho-
rylation of the RLC associated with IIA or IIB is differentially
regulated by Rho kinase, suggesting that at least part of how IIA
and IIB perform discrete cellular functions is via selective reg-
ulation downstream from different signaling pathways.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents—Monoclonal anti-vinculin (VIN-
11-5, #V-4505) andmonoclonal anti--actin (AC-15, #A-5441)
were purchased from Sigma-Aldrich. Polyclonal myosin light
chain 2 (#3672), polyclonal phospho-myosin light chain 2 (Ser-
19, #3671), and polyclonal phospho-myosin light chain 2 (Thr-
18/Ser-19) antibodies were purchased from Cell Signaling
Technology. Polyclonal nonmuscle myosin II heavy chain A
(#PRB-440P) and polyclonal nonmuscle myosin II heavy chain
B (#PRB-445P) were purchased from Covance Research Prod-
ucts. Fluorescein-conjugated AffiniPure goat anti-mouse IgG
(#115-095-146) and Cy3-conjugated AffiniPure goat anti-rab-
bit IgG (#111-166-003) were purchased from Jackson Immu-
noResearch Laboratories, Inc. Rhodamine-conjugated phalloi-
din was fromMolecular Probes (#R415), and Y-27632was from
Calbiochem (#688000).
Cell Line and Culture Conditions—The cell lines used in this
studywere the epithelial-derived, lung carcinomaA549 cell line
and the epithelial-derived, breast adenocarcinoma MDA-MB-
231 cell line. Both lines were maintained in Dulbecco’s modi-
fied Eagle’smedium supplementedwith 10% fetal bovine serum
(heat-inactivated for A549) and antibiotics (100 units/ml peni-
cillin and 100g/ml streptomycin) in a humidified atmosphere
of 5% C02 at 37 °C.
Myosin Heavy Chain Small-inhibitory RNAs (siRNA) Deple-
tion—All sense and antisense siRNA oligos were synthesized
by Dharmacon RNA Technologies and annealed. Target
sequences for humanmyosin II isoforms are nonmusclemyosin
heavy chain IIA (siIIA#1, TCTTGTGCTACTCTAGGA;
siIIA#2, GATCAATCCATCTTGTGCA), nonmuscle myosin
heavy chain IIB (siIIB#1, GACCACTGTGGACTCTAAA;
siIIB#2, GTGGTATTACAGACATTCA), and firefly luciferase
(GL2) for negative control. Transfection of siRNA (200 pmol)
was performed using Oligofectamine reagent according to the
manufacturer’s protocol. Cells were30–40% confluent at the
time of transfection. Assays were performed on the siRNA-
depleted cells 96 h post-transfection, the time of maximum
depletion. Cells were allowed to incubate with siRNA at least
24 h before changing media or replating for assays. All pheno-
types examined were verified with both sets of siRNA, but all
data shown were collected using siIIA#1 and siIIB#1, except
where indicated.
Wound Healing Assay—Control and siIIA- and siIIB-trans-
fected A549 cells were replated on plastic culture dishes 48 h
post-transfection and cultured for an additional 48 h to pro-
duce a confluent monolayer. Wounds were made in the mono-
layer using a Cell Lifter (Costar #3008), producing a wound of
250 m. Loose cells were washed off, and fresh media was
added to the cells immediately after wounding. Images were
obtained of the wounds at various times after wounding using a
NikonCoolPix 5700 digital camera fitted to the eyepiece port of
a Zeiss Axiovert 10 microscope using a MaxView Plus Adapter
System from ScopeTronix (#STMVP). Images were imported
into Adobe Photoshop CS, and wound widths were measured
based on images of a 5-mm micrometer treated in the same
manner. Distance migrated was calculated as the difference
between the wound width at the time of the image and the
initial wound width. Rate of wound closure was calculated as
the slope of the linear regression of the plot of distance
migrated versus time, combining the results from four separate
experiments.
VideoMicroscopy—Videos of wound healing migration were
made of wounds that were prepared in the same way as the
wound healing assay, except the cells were replated onto
fibronectin-coated (50 g/ml) glass bottom microwell dishes
(MatTek #P35G-0-10-C). Images of migrating cells were
obtained every 5 min for 8 h (control and IIA-depleted cells) or
16 h (IIB-depleted cells) using a Zeiss axiovert 200 microscope
equipped with a heated and humidified incubation chamber
and a Hamamatsu ORCA-ER cooled charge-coupled device
camera (Zeiss). Images were processed using Metamorph
Image software (Universal Imaging). Time stamps were
adjusted to reflect time after wounding. For videos of isolated
cell migration the control, siIIA- and siIIB-transfected A549
cells were replated at low density onto fibronectin-coated (50
g/ml) glass bottom microwell dishes 48 h post-transfection
and cultured for an additional 48 h. Before imaging themedium
was changed to Leibovitz’s L-15 medium (Invitrogen #21083-
027) supplemented with 10% heat-inactivated fetal bovine
serum, 10 mM HEPES, and antibiotics. Images were acquired
every 3min for 2 h using aNikon Eclipse TE2000-Emicroscope
with a heated stage and a Nikon DXM 1200-F digital camera.
Imageswere processed usingMetamorph Image software (Uni-
versal Imaging).
Immunofluorescence Microscopy—Control and siIIA- and
siIIB-transfected cells were replated on fibronectin-coated (50
g/ml) 22 22-mm coverslips in 6-well plates 48 h post-trans-
fection and cultured for an additional 48 h. Cells were fixed
using 3% paraformaldehyde, 2% sucrose in phosphate-buffered
saline (PBS) (pH 7) for 15–20min and permeabilized with 0.2%
Triton X-100 in PBS for 5 min. Nonspecific binding was
blocked with 5% fetal bovine serum in phosphate-buffered
saline plus 0.1% Triton X-100 followed by either a 1-h incuba-
tion at room temperature or an overnight incubation at 4 °C
with the described anti-vinculin, anti-IIA, or anti-IIB antibod-
ies diluted to 1:50–1:100 in blocking buffer followed by a 1-h
incubation at room temperature with the appropriate fluoro-
chrome-conjugated secondary antibodies. F-actin was labeled
using rhodamine-conjugated phalloidin diluted to 33 nM in
blocking buffer and incubated for 5–10 min. Coverslips were
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mounted onto slides using ProlongAntifade (Molecular Probes
#P7481) with 1 g/ml 4,6-diamidino-2-phenylindole to visu-
alize DNA. Images were obtained on a Zeiss AxioImager.D1
coupled with a Zeiss AxioCam MRm monochrome cooled-
CCD camera and analyzed with AxioVision software release
4.4.
Cell Spreading Assay—Control and siIIA- and siIIB-trans-
fected A549 cells were released into a monocellular suspension
using the non-trypsin Cellstripper solution (Cellgro #25-056-
CI) 48 h post-transfection and replated (5 104) onto fibronec-
tin-coated (50 g/ml) 22  22-mm coverslips in 6-well plates
and allowed to spread for an additional 48 h. These cells were
then fixed, and F-actin was labeled with rhodamine-conjugated
phalloidin as described above. For Rho kinase (ROCK) inhibi-
tion, wild type cells were incubated with Y-27632 (10 M) for
2 h before fixation. Images of the phalloidin-stained cells were
obtained on a Zeiss AxioImager.D1 coupled with a Zeiss Axio-
Cam MRm monochrome cooled-CCD camera. The cell areas
marked by phalloidin were traced and calculated using AxioVi-
sion software release 4.4. The histograms represent the com-
bined data from three separate experiments, with 30 cellsmeas-
ured per experiment.
Cell Rounding Assay—Control and siIIA- and siIIB-trans-
fectedMDA-MB-231 cells (5 104) were replated on fibronec-
tin-coated (50 g/ml) 22  22-mm coverslips in 6-well plates
48 h post-transfection and cultured for an additional 48 h. The
cells were starved of serum overnight (Dulbecco’s modified
Eagle’s medium with 1% fatty acid-free bovine serum albumin,
10mMHEPES, and antibiotics), which induced a flattenedmor-
phology. The cells were then treated with starvation media
containing 1 unit/ml human -thrombin (Enzyme Research
Laboratories) for 30 min and immediately fixed in paraformal-
dehyde. To visualize the cells, F-actin was labeled with rhoda-
mine-conjugated phalloidin, as described above. For ROCK
inhibition, control siRNA-transfected cells were pretreated
with 10 M Y-27632 for 20 min before thrombin treatment.
Images of four random high-power fields were obtained on a
Zeiss AxioImager.D1 coupled with a Zeiss AxioCam MRm
monochrome cooled-CCD camera, and the percent of rounded
cells was determined. Data represent the mean  S.E. from
three separate experiments, with150 cells counted from each
experiment.
Immunoprecipitation Assay—MDA-MB-231 cells (1.5 
106) were plated in 10-cm culture dishes and grown to 80%
confluency, then starved of serum overnight (Dulbecco’s mod-
ified Eagle’s mediumwith 1% fatty acid free bovine serum albu-
min, 10 mM HEPES, and antibiotics). Cells were then treated
with thrombin (1 unit/ml) for 5 min with or without a 20-min
pretreatment of 10 M Y-27632. After thrombin treatment the
cells werewashed oncewith ice-cold phosphate-buffered saline
followed by lysis in buffer C (50 mM Tris HCl (pH 7.5), 300 mM
NaCl, 50mMNa4P2O7 (pH 6.75), 100mMNaF, 1mMEGTA, 2.5
mM ATP, 1% Triton X-100, 1 M phenylmethylsulfonyl fluo-
ride, 1 M microcystin, 5 g/ml leupeptin, and 10 g/ml apro-
tinin). Cell lysates were briefly sonicated, then cleared by spin-
ning for 10min at 14,000 rpmat 4 °C in anEppendorf centrifuge
5415 C. For immunoprecipitation, 800–1500 g of total lysate
was diluted to 1.5–2 g/l with buffer C and incubated with
either 5g of IIA or 10g of IIB antibody on a rocker overnight
at 4 °C. After overnight incubation, 25 l of a 1:3 slurry of pre-
washed protein A-Sepharose CL-4B beads (GEHealthcare, for-
merly Amersham Biosciences #17-0780-01) were added and
incubated for an additional 1.5 h on the rocker. The immuno-
precipitates were washed 3 times with 300 l of buffer C, then
boiled in 3 SDS sample buffer for 5min. The immunoprecipi-
tates were separated by SDS-PAGE and subjected to immuno-
blot analysis. To make the loading across isoforms equivalent,
25% of the immunoprecipitate loaded for IIB was loaded for
IIA. For quantification of RLC phosphorylated on Ser-19
(P-RLC(Ser-19)) stimulation, the immunoblots were scanned
and subjected to densitometry analysis usingOdyssey v1.2 soft-
ware. Loading was corrected by the amount of myosin II heavy
chain in each lane. The corrected phosphorylation values from
the thrombin  Y-27632-treated samples were divided by the
basal values from the starved, unstimulated samples to deter-
mine the -fold thrombin-induced phosphorylation. The data
are represented as the mean of three separate experiments plus
S.E.
In Vivo [32P]Orthophosphate Labeling and Immunoprecipi-
tation Assay—This immunoprecipitation assay was performed
the same as above, except after overnight serum starvation the
cellswere incubated in phosphate-freemedia (Dulbecco’smod-
ified Eagle’s medium without sodium phosphate (Invitrogen
#11971-025) supplementedwith 10mMHEPES and antibiotics)
for 2 h followed by labeling with 3 ml of phosphate-free media
containing 1 mCi/ml [32P]orthophosphate (GE Healthcare
#PB-13) for 3 h. Cells were treated with thrombin with or with-
out Y-27632 and lysed as described above except without son-
ication. After separation of the immunoprecipitates by SDS-
PAGE, the gel was silver-stained and dried for PhosphorImager
analysis. The amount of radioactivity incorporated intomyosin
IIA and IIB heavy chains, as well as the RLC was quantified
using a PhosphorImager 445 SI scanner (GE Healthcare) along
with IPLab Gel version 1.5 software (Signal Analytics Corp.).
The radioactivity in each band was corrected by the amount of
myosin II heavy chain immunoprecipitated, which was deter-
mined by densitometry analysis of the silver-stained gel using
Odyssey Version 1.2 software. The corrected phosphorylation
values from the thrombin  Y-27632-treated samples were
divided by the basal values from the starved, unstimulated sam-
ples to determine the -fold thrombin-induced phosphorylation.
The data are represented as the mean of five separate experi-
ments plus S.E.
Data Analysis—All data were analyzed using Statview 5.0.1
(SAS Institute Inc.). For the wound healing assay the regression
for each treatment represents the combined data from four
separate experiments. The differences between the regressions
for each treatment were compared via analysis of covariance.
For the cell spreading assay cell areas are represented both as
histograms and as the means  S.E. The histograms were ana-
lyzed first non-parametrically by the global Kruskal-Wallis test
incorporating all variables followed by the Mann-Whitney U
test for pairwise comparisons. All other results presented as the
means  S.E. were analyzed first by analysis of variance fol-
lowed by Fisher’s protected least significant difference to char-
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acterize pairwise comparisons. Significance for all tests was
assumed at p  0.05.
RESULTS
siRNADepletion of IIA or IIB Has Opposing Effects on Epithe-
lial Cell Wound Healing Migration—When a wound is intro-
duced into amonolayer of epithelial cells, the cells on both sides
of the wound migrate coordinately as sheets in an effort to
“close” the wound. To examine the distinct roles of IIA and IIB
in epithelial sheet migration, we developed isoform-specific
siRNAs to characterize the loss-of-function phenotypes associ-
ated with depletion of each isoform. Western blots of whole-
cell extracts from cultured A549 cells (Fig. 1A) demonstrate
that this cell line expresses both IIA and IIB and that we could
successfully deplete one isoform without affecting the levels of
the other isoform. To verify that the phenotypes observed with
siRNAwere specific, we designed two siRNAs for each isoform
that targeted different regions of the mRNA transcripts. All
phenotypes were reproduced with both siRNAs for each
isoform.
We first characterized the effect depletion of IIA or IIB had
on the ability of epithelial cells to perform wound healing
migration. Fig. 1B demonstrates that control cells (A549 cells
transfected with siRNA directed against luciferase) reproduc-
ibly closed the wound at a rate of 9.0 0.5 m/h. siRNA deple-
tion of IIA or IIB both resulted in changes in the rate of wound
closure but, interestingly, the changes occurred in opposite
directions. Specifically, IIA-depleted cells exhibited a 2-fold
increase (18.0  1.1 m/h) in the rate of wound closure,
whereas IIB-depleted cells covered the cell-free area at a rate
60% that of control cells (5.3  0.6 m/h). The differences in
the rate of wound closure for both the IIA- and IIB-depleted
cells were statistically significant from that of the control cells
(p  0.0001). ROCK is a regulator of myosin II activity as it
promotes RLC phosphorylation (21, 22). Thus, the small mole-
cule inhibitor of ROCK, Y-27632 (23–25), has been used to
examine the cellular functions of myosin II. Our data show that
inhibition of ROCKwith 10MY-27632 resulted in an increase
in the rate of A549 wound closure that was significantly differ-
ent from control but not IIA-depleted cells (22  3 m/h).
Small molecule inhibitors of ROCK in previous studies have
had varied effects on cell migration, depending on cell type and
migration model. Although ROCK inhibitors have been shown
to decrease the transwell migration of PC3 prostatic carcinoma
cells and human umbilical vein endothelial cells (26, 27), the
increase in A549 cell wound closure rate observed with
Y-27632 treatment here is consistent with reports demonstrat-
ing that inhibition of ROCK leads to increases in the rate of
fibroblast wound migration (28).
IIA and IIB Distinctly Regulate Cellular Protrusions—In
examining videos of control and IIA- and IIB-depleted cells
migrating into a wound, we observed marked differences in
membrane ruffling and lamellipodial protrusions between the
cell types (Fig. 2 and supplemental Videos 1–3). Control cells
entering thewound (Fig. 2 and supplemental Video 1) extended
a generally broad, less phase-dense lamellipodial skirt that
underwent repetitive periods of extension and retraction. IIA-
depleted cells, however, exhibited a leading edge thatwas highly
protrusive and one that retracted back toward the cell body less
frequently than the control cells (Fig. 2 and supplemental Video
2). The lamellipodia of IIA-depleted cells also extended further
into the wound, with extremely broad protrusions that often
developed narrower, finger-like projections at the very front. In
contrast, IIB-depleted cells exhibited diminished membrane
ruffling and did not generate sustained protrusions (Fig. 2 and
supplemental Video 3).
The distinct lamellipodia exhibited by the control and IIA-
and IIB-depleted cells were examined further by fixation of cells
migrating into a wound followed by visualization of the actin
cytoskeleton via staining with rhodamine-conjugated phalloi-
din. The top panel of Fig. 3 demonstrates that the extended
lamellipodia exhibited by control A549 cells contained bundles
of F-actin, which most frequently formed parallel to the direc-
tion of protrusion (Fig. 3, arrow in top panel). The regions of the
lamellipodia around these bundles stained brightly with phal-
loidin but appeared more diffuse, with little ultrastructure vis-
ible in the light microscope (Fig. 3, arrowhead in the top panel).
This latter pattern of phalloidin staining is consistent with an
organization of F-actin into a fine meshwork and is character-
istic of lamellipodial protrusions (28). The leading edges of IIA-
FIGURE 1. IIA- and IIB-depleted A549 cells display opposite migration
phenotypes. A, Western blot analysis of A549 whole cell lysates demonstrat-
ing efficiency and specificity of isoform depletion. A549 cells were transfected
with 200 pmol of siRNA directed against luciferase (Control), IIA (siIIA), or IIB
(siIIB), and lysates were prepared 96 h post-transfection, the time of maximum
depletion. Two siRNAs that were targeted to different regions of the tran-
script were designed for each myosin II isoform, and all phenotypes were
verified using both sets of siRNA. Equal protein loading was verified by blot-
ting for -actin. B, Control and IIA- and IIB-depleted A549 cells were grown to
confluency, and a wound was introduced into the monolayer 96 h post-siRNA
transfection. Images of the wound were obtained at various time points after
wounding, and the distance migrated was determined as described under
“Experimental Procedures.” To examine the effect of ROCK inhibition on
wound healing, control cells were treated with Y-27632 (10 M) for 20 min
before wounding and throughout the assay. Lines represent the best-fit linear
regressions of the combined results from three separate experiments. The
rates of migration (slopes) for each cell type are as follows: control  9.0  0.5
m/h, IIA-depleted  18.0  1.1 m/h, IIB-depleted  5.3  0.6 m/h;
Y-27632-treated  22  3 m/h (represented as the mean  S.E.) *, All rates
are statistically different from controls (p  0.0001) by analysis of covariance,
but the migration rates of IIA-depleted and Y-27632 treated cells are not
statistically different.
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depleted cells displayed few to no bundles of F-actin, and the
lamellipodia were very broad and thin compared with those of
the control cells (Fig. 3,middle panel). At the other extreme, the
lamellipodia extended by the IIB-depleted cells were small (Fig.
3, arrow in bottom panel). Furthermore, these cells formed
prominent bundles of F-actin that ran along the leading edge,
parallel to the wound (Fig. 3, arrowhead in bottom panel),
rather than orthogonal to the wound as in the control cells.
The cytoskeletal dynamics that occur during cell spreading
are commonly considered to be similar to the events occurring
at the leading edge of migrating cells (29); thus, we also exam-
ined the effects of IIA or IIB depletion as well as Y-27632 treat-
ment on the ability of A549 cells to spread on fibronectin. An
examination of the distribution of control cell areas after
spreading revealed a bell-shaped curve that skewed slightly to
the right and averaged 1820  65 um2 (Fig. 4). Consistent with
their decreasedmigration andmore retractilemorphology, IIB-
depleted cells were significantly less well spread than the con-
trols with a mean cell area of 1100  49 um2. In contrast, the
spread areas of cells depleted of IIA or treated with Y-27632
were both significantly skewed to the right, demonstrating
mean cell areas of 2380  78 and 2620  91 um2, respectively.
These cell-spreading phenotypes correlate strongly with the
migration and protrusion pheno-
types observed in thewoundhealing
assay.
Previous studies have demon-
strated that inhibition of Rho-
ROCK signaling and myosin II
activity result in increased cellular
protrusions all around the cell, lead-
ing to the hypothesis that Rho-
ROCK signaling, in conjunction
with myosin II contractility, is
required to restrict protrusions to
the leading edge (24, 30). Under this
hypothesis, cells in which myosin II
activity is absent would protrude
dynamically on all sides. However,
in a wound, protrusions can pro-
trude only in one direction, into the
wound. We, therefore, made time-
lapse videos of sparsely plated, iso-
lated cells to examine their protru-
sions. As predicted, IIA-depleted
cells showed dynamic protrusions
on all sides of the cell, with little net
movement of the cell body (Fig. 5
and supplemental Video 5). This
was in contrast to control cells,
which demonstrated more persis-
tent protrusions and inwhich trans-
locations of the entire cell body
were common (Fig. 5 and supple-
mental Video 4). As expected, the
IIB-depleted cells exhibited little
movement or protrusional activity
(Fig. 5 and supplemental Video 6).
Taken together the above data suggest that IIA and IIB both
perform important but distinct roles in regulating cell protru-
sions during cell migration.
siRNA Depletion of IIA or IIB Results in Unique Changes in
Focal Adhesions—Myosin II-based contractility, via contrac-
tion of F-actin into stress fiber bundles, is required for the
assembly of focal adhesions (12). Because changes in substrate
adhesion are known to modulate cellular protrusions (31), one
hypothesis to explain the distinct protrusion phenotypes
observed in IIA- and IIB-depleted cells is through differential
regulation of focal adhesions by IIA and IIB. Accordingly, we
examined the focal adhesions and stress fibers formed in con-
trol and IIA- and IIB-depleted and Y-27632-treated cells by
dual staining for the focal adhesion protein vinculin and F-ac-
tin. Fig. 6 shows that control A549 cells cultured on fibronectin
exhibit punctate vinculin staining, indicative of focal adhesions,
throughout the cell cortex andmost strongly in the cell periph-
ery. These focal adhesions anchored actin stress fibers, as evi-
denced by the yellow punta in the merge of the vinculin and
phalloidin staining (Fig. 6, seeMerge). IIA-depleted and 10 M
Y-27632-treated cells both exhibited a more diffuse, cytoplas-
mic pattern of vinculin staining that was most intense around
the nucleus and diminished toward the periphery. And unlike
FIGURE 2. Stills from supplemental videos of wound healing migration. Control and IIA and IIB siRNA-
transfected A549 cells were plated on fibronectin-coated (50 g/ml), glass-bottomed 35-mm plates 48 h
post-transfection and grown to a confluent monolayer. Wounds were introduced into the monolayer 96 h
post-siRNA transfection. Phase/contrast images were obtained every 5 min for 8 h (Control and IIA-depleted) or
16 h (IIB-depleted) post-wounding. Images comprise a series of video stills at 0.5, 2.5, 4.5, and 6.5 h post-
wounding demonstrating differences in the rate of wound closure. See also supplemental Videos 1–3.
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control cells, few to no focal adhesions were observed, although
the smaller, Rac-regulated focal complexes (30, 32) may still be
present, especially in the peripheral regions. These cells were
also nearly devoid of stress fibers but did occasionally display
some bundled F-actin (Fig. 6). In addition, the IIA-depleted and
Y-27632-treated cells exhibited amore protrusivemorphology,
which along with the changes in focal adhesions and stress
fibers, is consistent with previous descriptions of decreased
Rho-ROCK-mediated contractility (24, 28). In the IIB-depleted
cells focal adhesions were observed; however, they were
restricted to the cell perimeter. IIB-depleted cells were retrac-
tile and polygonal in morphology, with prominent bundles of
F-actin running the perimeter of the cells, terminating in the
peripheral focal adhesions (Fig. 6, see Merge). These data
strongly suggest that IIA and IIB differentially contribute to
focal adhesion formation and/or maintenance. Furthermore,
the observation that IIA- but not IIB-depleted cells exhibit a
lack of focal adhesions and stress fibers similar to that of
Y-27632-treated cells suggests that IIA is specifically required
for Rho-induced contractility.
IIA and IIB Exhibit Distinct Subcellular Localization Patterns—
Many previous studies have examined the subcellular localiza-
tion patterns of IIA and IIB, with a broad range of cell type-
specific distributions having been described (33–36). What is
consistent is that IIA and IIB display differences in their distri-
butions, especially in motile cells. In A549 cells cultured on
fibronectin, both IIA and IIB appeared as puncta distributed
throughout the cytoplasm,with these puncta occasionally orga-
nizing into linear arrays that coincidewith stress fibers (Fig. 7,A
and B, seeMerge). IIA appeared to associatemore strongly with
stress fibers, however, as indicated by the yellow coloring of the
merge between IIA and phalloidin staining (Fig. 7A). Close
examination of IIA staining revealed that this isoform distrib-
uted broadly throughout the cytoplasm, extending nearly to the
very leading edge (Fig. 7A). Furthermore, IIA commonly co-
localized with focal adhesions, with the linear arrays of IIA
staining often terminating in vinculin-containing structures
(Fig. 7B, arrows). IIB staining, however, was observed most
strongly in the rear and along the sides of cells, where they were
not protruding, and overlappedwith F-actin in these regions. In
areas of protrusions, both in isolated cells (Fig. 7B) or polarized
cells along the edge of a wound (Fig. 7A), IIB staining was less
intense. Thus, in polarized cells IIA appeared enriched in the
lamellipodia relative to IIB. Unlike IIA, IIB staining lacked
intensity in areas where focal adhesions were in abundance and
did not generally merge with vinculin staining, which is espe-
cially visible in the leading edge of the cell (Fig. 7B, arrows).
FIGURE 3. Leading edge morphologies of IIA- and IIB-depleted cells. Con-
trol and IIA- and IIB-depleted A549 cells were grown to a confluent monolayer
on fibronectin-coated (50 g/ml) glass coverslips. A wound was introduced
into the monolayer 96 h post-siRNA transfection, and the cells were allowed
to migrate into the wound for 90 min, then fixed with paraformaldehyde and
stained with rhodamine-conjugated phalloidin to visualize F-actin. Arrows
indicate bundles of F-actin, and the arrowheads indicate areas of protrusion.
Scale  10 m.
FIGURE 4. IIA-depleted cells exhibit increased cell spreading, whereas
IIB-depleted cells are retractile. Control and IIA- and IIB-depleted A549 cells
were released into suspension using the non-trypsin-based Cellstripper solu-
tion (see “Experimental Procedures”) 48 h post-siRNA transfection, then
replated in full serum on fibronectin-coated (50 g/ml) glass coverslips.
These cells were then allowed to attach and spread for an additional 48 h.
After spreading, the cells were paraformaldehyde-fixed, and F-actin was
labeled using rhodamine-conjugated phalloidin. For ROCK inhibition wild
type cells were incubated with Y-27632 (10 M) for 2 h before fixation. Cell
areas were determined as described under “Experimental Procedures.” Histo-
grams demonstrating the distribution patterns of cell areas of asynchronous
populations are shown and represent the combined data from three experi-
ments with 30 cells/experiment measured. *, non-parametric analysis of the
data demonstrated that distribution of IIA- and IIB-depleted cells as well as
Y-27632-treated cells were significantly different from that of the control cells
(p  0.0001). #, the average cell areas are also significantly different from
control cells (p  0.0001). Note that a significant difference did not exist
between IIA-depleted and Y-27632 treated cells.
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Interestingly, under the light microscope, IIA staining occa-
sionally exhibited an area of low intensity that was coincident
with the nucleus, which was not observed as often with IIB
staining (Fig. 7B). A careful analysis of IIA and IIB staining
patterns with a confocal microscope would provide further
interesting information about the differential localizations
of these isoforms. However, in general, the localization pat-
terns of both myosin II isoforms in A549 cells observed here
are consistent with those previously described in endothelial
cells (36, 37).
IIA but Not IIB Is Required for ROCK-mediated, Thrombin-
induced Cell Rounding—In all the above phenotypes, IIA-de-
pleted cells were comparable with cells in which ROCK activity
was inhibited (Figs. 1, 5, and 6). This correlation suggests that
IIA is specifically required for contractile events downstreamof
the Rho-ROCK signaling pathway in a way that is consistent
with the classically described functions of myosin II. To char-
acterize thismore carefully, we examined the specific contribu-
tions of IIA and IIB to another process in which myosin II con-
tractility is required downstream of Rho-ROCK signaling,
namely thrombin-induced cell rounding (5, 38, 39). Serum-
starved MDA-MB-231 cells display a flattened morphology;
however, after thrombin treatment the cells round up and
undertake a spherical shape (Fig. 8B). Thirty minutes after
stimulation of starved MDA-MB-231 cells with 1 unit/ml
thrombin, 57  4% of the control cells have undergone cell
rounding (Fig. 8C). MDA-MB-231 cells, either depleted of IIA
or treated with 10 M Y-27632, exhibited an equivalent, statis-
tically significant block (p  0.0001) in cell rounding, with only
15  1 and 13  2% of these cells
responding to thrombin, respec-
tively (Fig. 8C). IIB is not required
for cell rounding, and in fact a
higher percentage of IIB-depleted
cells were round (72  3%, p 
0.006) after thrombin treatment
when compared with control cells.
This observation, when considered
along with the data from Figs. 3–5,
demonstrating that IIB-depleted
cells are less-well spread and exhibit
fewer protrusions than control cells,
suggests that cells depleted of IIB
display a higher propensity to
undergo retraction than extension.
Furthermore, these data support the
idea that IIA is specifically required
for contractile events downstream
of Rho-ROCK signaling.
ROCK Differentially Regulates
Phosphorylation of the RLC Associ-
ated with IIA and IIB—The above
data demonstrate that IIA and IIB
perform distinct functions in the
cell. However, how these isoforms
are regulated differently is unclear.
Myosin II activity is regulated in
large part through phosphorylation
of the RLC, with Ser-19 of the RLC considered to be the major
site of phosphorylation (2, 40, 41). Phosphorylation at Ser-19
both increases the actin-activated ATPase activity of myosin II
and promotes myosin II filament assembly. Multiple kinases
have been shown to be able to phosphorylate Ser-19, including
myosin light chain kinase, ROCK, p21-activated kinase, and
zipper-interacting protein kinase (21, 42–44). Furthermore,
ROCK has been shown to regulate the phosphorylation of the
RLC directly (21) as well as indirectly by phosphorylation and
inhibition of the targeting subunit of the RLC phosphatase,
MYPT-1 (22, 45). However, whether ROCK or any kinase dif-
ferentiates between the RLC specifically associated with IIA
and IIB (hereafter, IIA-RLC and IIB-RLC, respectively) has not
been carefully examined. Thus, onemechanismof isoform-spe-
cific regulation that could account for the observed correlation
between IIA depletion and ROCK inhibition is a differential
regulation of IIA- and IIB-RLCphosphorylation byROCK,with
the kinase preferentially regulating IIA-RLC phosphorylation.
To examine whether ROCK differentiates between IIA- and
IIB-RLC, we immunoprecipitated IIA and IIB with isoform-
specific antibodies and characterized the thrombin-induced
changes in phosphorylation of the RLC that co-immunopre-
cipitated specifically with each heavy chain isoform. This
immunoprecipitation assay was performed on lysates prepared
from MDA-MB-231 cells that were starved and treated with
thrombin in the presence or absence of Y-27632, similar to the
cell rounding assay. Fig. 9A shows the immunoblot analysis of
IIA and IIB immunoprecipitates from MDA-MB-231 cells
treated with thrombin alone (T), thrombin plus Y-27632
FIGURE 5. Protrusional activities of isolated control, IIA-and IIB-depleted cells are distinct. Control and
IIA- and IIB-depleted cells were replated on fibronectin-coated (50 g/ml) glass-bottomed dishes 48 h post-
siRNA transfection and cultured for an additional 48 h. The protrusion activities of each cell type were then
examined by acquiring time-lapse phase/contrast images of the same view field every 3 min for 2 h. Shown
here are images obtained at 0, 19, 79, and 119 min (from left to right in each row). Arrowheads serve as reference
points to follow the morphological changes for each cell type. Note that control cells exhibit sustained protru-
sions and cell body translocations. IIA-depleted cells, however, are much more dynamic, first protruding in one
direction followed by retraction and protrusion in a new direction, with little net movement of the cell body.
IIB-depleted cells exhibit only minor changes in morphology over the same 2-h time period. See supplemental
Videos 4 – 6.
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(TY), or left untreated (U). The immunoblots of IIA and IIB
heavy chains with the isoform specific antibodies demonstrate
that equivalent amounts of IIAor IIBwere immunoprecipitated
across treatments; however, the amount of IIB immunoprecipi-
tated was consistently low compared with IIA. Furthermore,
immunoprecipitation was specific for each isoform, as no IIB
was detected in the IIA immunoprecipitates, and vice versa
(data not shown).
We next probed the IIA and IIB immunoprecipitates with
a phospho-specific antibody that specifically recognizes
P-RLC(Ser-19) to examine whether ROCK differentially regu-
lates the phosphorylation of IIA- and IIB-RLC at that site in
response to thrombin. Fig. 9A shows that thrombin induced an
increase in phosphorylation at Ser-19 on IIA-RLC and that this
phosphorylation was completely inhibited by pretreatment
with 10 M Y-27632. A similar result was observed when using
an antibody that recognizes RLC doubly phosphorylated on
residues threonine 18 and serine 19 (data not shown). Treat-
ment of these cells with thrombin  Y-27632 induced a similar
trend in IIB-RLC phosphorylation at Ser-19 as on IIA-RLC.
However, the thrombin-induced stimulation of IIB-RLC phos-
phorylationwas consistently weaker than that observed on IIA-
RLC, and when quantified by densitometry, the mean -fold
stimulation of IIB-RLC phosphoryl-
ation was less than two-thirds that
of IIA-RLC (Fig. 9B).
As a more sensitive measure of
changes in phosphorylation, we
repeated the immunoprecipitation
assay after first labeling the cells in
vivo with radioactive [32P]ort-
hophosphate. Besides being a more
sensitive method, labeling cells with
radioactive phosphate enabled us to
examine whether ROCK differen-
tially regulated the phosphorylation
of IIA and IIB on any site, including
any on the heavy chain. This assay
was performed in the same way
as the above immunoprecipitation
assay, except that the cells were first
incubated with 1 mCi/ml [32P]ort-
hophosphate before treatment with
thrombin or Y-27632. The immu-
noprecipitates were separated by
SDS-PAGE, and the amount of
radioactive phosphate that was
incorporated into IIA and IIB heavy
chains as well as IIA- and IIB-RLCs
was determined by PhosphorIm-
ager analysis. A silver stain of the gel
(Fig. 9C, top panel) demonstrates
that equivalent amounts of IIA
and IIB were immunoprecipitated
across treatments. Again, less IIB
was consistently immunoprecipi-
tated compared with IIA, and to
make the loading across isoforms
equivalent, 25% of the immunoprecipitate loaded for IIB was
loaded for IIA. The amounts of IIA and IIB that were immuno-
precipitated and loaded on the gelwere quantified by densitom-
etry and used for normalization. Quantification of the
radioactivity incorporated into IIA and IIB heavy chains by
PhosphorImager analysis revealed that IIB was labeled with
higher amounts of radioactivity than IIA heavy chain, even in
the unstimulated sample (data not shown). This is consistent
with reports from the literature, as several more sites of phos-
phorylation have been reported in the C-terminal tail region of
the IIB heavy chain compared with the homologous region of
the IIA heavy chain (2, 46). Despite the presence of detectable
levels of phosphorylation on both IIA and IIB in the basal state,
treatment with thrombin and/or Y-27632 did not have a signif-
icant effect on the amount of radioactive phosphate that was
incorporated into either heavy chain (data not shown).
A representative PhosphorImager scan of IIA- and IIB-RLC
phosphorylatedwith radioactive phosphate is shown in the bot-
tom panel of Fig. 9C. This assay was repeated fives times, and
the -fold increase inRLCphosphorylation induced by thrombin
over the basal level of phosphorylation in the unstimulated
sample was determined for both IIA- and IIB-RLC. The bar
graph in Fig. 9D, similarly to Fig. 9B, demonstrates that whereas
FIGURE 6. IIA- and IIB-depleted cells exhibit distinct focal adhesion phenotypes. Control and IIA- and
IIB-depleted A549 cells were plated on fibronectin-coated (50 g/ml) glass coverslips 48 h post-siRNA trans-
fection and cultured for an additional 48 h. The cells were then paraformaldehyde fixed and immunostained
with anti-vinculin monoclonal antibody (green) to mark focal adhesions and rhodamine-conjugated phalloidin
(red) to label F-actin. For ROCK inhibition, control siRNA-transfected cells were treated with Y-27632 (10 M) for
2 h before fixing. In the merge 4,6-diamidino-2-phenylindole (blue) labels DNA. Scale  10 m.
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thrombin stimulated phosphorylation of the RLC associated
with both myosin II isoforms, the stimulation on IIB-RLC was
50% that of IIA-RLC. Furthermore, pretreatment with
Y-27632 completely inhibited the thrombin-induced phospho-
rylation. Taken together these data suggest that thrombin pref-
erentially induces phosphorylation of IIA-RLC, which is medi-
ated through the Rho-ROCK signaling cascade. This result is
consistent with the observation that IIA is selectively required
for thrombin-induced cell rounding and provides support for
the hypothesis that IIA and IIB can be regulated by distinct
signaling pathways.
DISCUSSION
The importance of myosin II for cellular contractile pro-
cesses has been well documented. However, until recently little
was known about the unique cellular functions of the different
myosin II isoforms, IIA and IIB. Data presented here demon-
strate that, indeed, IIA and IIB are both required for normal
migration but in distinct ways. Surprisingly, siRNAdepletion of
each isoform resulted in opposite migratory phenotypes, with
IIA- and IIB-depleted cells exhibiting rates of wound healing
migration at 200 and 60% that of control cells, respectively
(Fig. 1B). Furthermore, cells depleted of IIA exhibited decreases
in stress fibers and focal adhesions, with concomitant increases
FIGURE 7. IIA and IIB exhibit distinct subcellular localizations. A, IIA and
IIB localizations in polarized cells on the edge of a wound. A549 cells were
plated on fibronectin-coated (50 g/ml) glass coverslips and cultured for
48 h to confluency. The monolayer was wounded, and the cells were
allowed to migrate for 60 min. The cells were then paraformaldehyde-
fixed and immunostained with polyclonal antibodies that are specific to
IIA (green, left column) or IIB (green, right column) to mark the myosins and
rhodamine-conjugated phalloidin to visualize F-actin (red). In the merge
4,6-diamidino-2-phenylindole (blue) labels DNA. Scale  10 m. Arrow-
heads indicate areas of leading edge protrusion. Note that IIA staining is
prominent in the lamellipodia, whereas IIB staining is most intense in the
rear of the cells. B, IIA and IIB localizations in isolated cells. A549 cells were
plated sparsely on fibronectin-coated (50 g/ml) glass coverslips for 48 h,
then paraformaldehyde-fixed and immunostained with an anti-vinculin
monoclonal antibody to mark focal adhesions (green) and polyclonal anti-
bodies that are specific to IIA (red, left column) or IIB (red, right column) to
mark the myosins. In the merge 4,6-diamidino-2-phenylindole (blue)
labels DNA. Scale  10 m. Arrows indicate areas of focal adhesion, where
IIA staining is present, but IIB staining is weak.
FIGURE 8. IIA-depleted and Y-27632-treated cells are deficient in throm-
bin-induced cell rounding. A, Western blots of MDA-MB-231 whole cell
lysates prepared 96 h post-siRNA transfection, demonstrating that although
less transfectable than A549 cells, siRNA depletion of IIA and IIB is achievable
in this cell line. B, representative phase/contrast images of control MDA-MB-
231 cells with and without 1 unit/ml thrombin treatment. Scale  20 m.
C, control and IIA- and IIB-depleted MDA-MB-231 cells were plated on
fibronectin-coated (50 g/ml) glass coverslips. After overnight serum starva-
tion the cells display a flattened morphology. The cells were then treated with
1 unit/ml thrombin (black bars) or left untreated (gray bars) for 30 min and
immediately paraformaldehyde-fixed. To visualize the cells, F-actin is labeled
with rhodamine-conjugated phalloidin. Images of four random high-power
fields were obtained, and the percent of rounded cells was determined. Data
represent the mean  S.E. from three separate experiments, with 150 cells
counted from each experiment. *, percent rounded cells after thrombin treat-
ment is significantly different from control cells (p  0.006). #, percent
rounded cells without thrombin is significantly different from control cells
(p  0.002).
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in cell protrusions, whereas IIB-depleted cells were at the oppo-
site end of the spectrum.With few protrusions and less spread-
ing on fibronectin, cells depleted of IIB exhibited a higher tend-
ency toward retraction than extension. The phenotypes
observed with IIA depletion are consistent with the generally
accepted functions ofmyosin II downstreamof Rho-ROCK sig-
naling (12, 24, 28, 47). Namely, Rho-ROCK-mediatedmyosin II
contractility promotes stress fiber and focal adhesion forma-
tion and is inhibitory to protrusion. Thus, one interpretation of
our data is that loss of IIA-based contractility relieves a restric-
tion on protrusions, whereas IIB has a limited role in protrusion
regulation. However, the observation reported here that IIB-
depleted cells are less well spread compared with control cells
suggests that IIB activity indeed facilitates cellular protrusions.
Because it is generally accepted that the force required to
produce membrane protrusions is generated by actin polymer-
ization (48, 49), our data raise the question as to how IIA and IIB
distinctly regulate cell protrusions. In light of the observations
that the protrusion as well as cell rounding phenotypes of IIA-
and IIB-depleted cells are opposite in nature (see Figs. 4 and 8),
one simple hypothesis is that IIA and IIB contractility counter-
act each other. Thus, depletion of one isoformwould result in a
shift in the balance of IIA- versus IIB-based contractility, result-
ing in the opposing phenotypes. Alternatively, it is known that
changes in substrate adhesion can modulate cell protrusions
(31) and that myosin II-mediated contractility is required
for focal adhesion assembly (12).
Therefore, the distinct ways in
which IIA and IIB regulate focal
adhesions (Fig. 6) may contribute to
the different protrusive phenotypes,
although the mechanism for this
remains unclear. Perhaps IIA and
IIB do the same thing, simply in dif-
ferent places. Support for this
hypothesis can be drawn from the
distinct distributions of IIA and IIB
(Figs. 7, A and B). For instance,
because IIB is of relatively low abun-
dance compared with IIA in the cell
periphery, IIB-depletion would be
expected to have little effect on
the assembly of peripheral focal
adhesions. Alternatively, because
the adhesive complexes necessary
for cell motility are heterogeneous
structures that exhibit a dynamic
life cycle consisting of periods
of assembly, maturation/mainte-
nance, and disassembly (50, 51), it is
possible that IIB is selectively
required for some other aspect of
focal adhesion regulation, such as
their centripetal translocations (14,
52). In the latter scenario, the
absence of IIB would again result in
an abundance of focal adhesions at
the cell periphery. A thorough char-
acterization of focal adhesion dynamics in live cells will be
instrumental to our complete understanding of the different
roles IIA and IIB play in adhesion and protrusion regulation.
Despite our observations that IIA and IIB perform distinct
cellular functions, it remains unclear why cells expressmultiple
myosin IIs, since each isoform appears to perform the same
basic molecular function. In considering this question, obser-
vations made from some cell types that are naturally enriched
for, or solely express a single isoform may offer important
insight. For instance, only IIA is detected in platelets (35, 53),
and the shape change necessary for platelet activation requires
myosin II-based contractility (4, 54). This large scale contractile
process is similar to thrombin-induced rounding ofMDA-MB-
231, which specifically requires IIA and not IIB. Thus, IIA may
be better suited for large scale contractile processes than IIB.
Support for this idea can be drawn from the observations that
IIA localizes broadly throughout the cytoplasm and that this
isoform moves actin at nearly three times the rate of IIB (33).
Conversely, IIB is enriched in neurons (34, 53), where a more
restrictive localization pattern and less powerful motor may
providemore delicate regulation of contraction, supporting the
complex process of neurite extension. The two cell types used
in this study express both myosin II isoforms, with IIA being
expressed at a higher level compared with IIB, similar to what
has been reported for endothelial cells (36). This suggests that
migrating cells require a balance of both myosin II isoforms to
FIGURE 9. ROCK preferentially regulates phosphorylation of RLC associated with IIA. MDA-MB-231 cells
were plated in 10-cm culture dishes and grown to 80% confluency, then starved of serum overnight. Cells were
then treated with thrombin (1 unit/ml) for 5 min with or without a 20-min pretreatment of Y-27632 (10 M). IIA
and IIB were immunoprecipitated using isoform-specific polyclonal antibodies followed with separation by
SDS-PAGE. A, Western blot of IIA and IIB immunoprecipitates (IP) using the isoform-specific antibodies (IIA and
IIB) and a phospho-specific polyclonal antibody that recognizes the RLC phosphorylated at Ser-19 (P-RLC (S19)).
Note that the film exposure time for the P-RLC(Ser-19) blot of the IIB immunoprecipitate is 10 times longer than
that for IIA. B, bar graph representing a quantification of the -fold RLC phosphorylation in thrombin (T, black) or
thrombin plus Y-27632 (TY, gray) immunoprecipitates over untreated (U, white) samples without thrombin
stimulation. The amount of RLC phosphorylation at Ser-19 was quantified by densitometry for three immuno-
blots and corrected by the amount of myosin II heavy chain immunoprecipitated. All three immunoblots
showed similar trends, and these data represent the mean of the three experiments plus S.E. C and D, [32P]or-
thophosphate labeling followed by IIA and IIB immunoprecipitation. Assay performed essentially the same as
in A, except the cells were first incubated in phosphate-free media for 2 h followed by labeling with phosphate-
free media containing [32P]orthophosphate (1 mCi/ml) for 3 h before thrombin treatment. C, representative gel
of silver-stained myosin II heavy chain (top) and PhosphorImager scan of the radioactivity incorporated into the
RLC (bottom). Note that to make the loading across isoforms equivalent, 25% of the immunoprecipitate
loaded for IIB was loaded for IIA. D, bar graph representing the amount of radioactivity incorporated into the
RLC as quantified by PhosphorImager analysis and corrected by the amount of myosin II heavy chain immu-
noprecipitated. Each bar represents the -fold RLC phosphorylation in thrombin (T, black) or thrombin plus
Y-27632 (TY, gray) immunoprecipitates over untreated (U, white) samples without thrombin stimulation.
Data represent the mean plus S.E. of five similar experiments.
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provide the proper contractile forces necessary at different
places in the cell at the proper time during the migration
process.
Last, our data as well as previous work by others provide
strong evidence supporting the idea that IIA and IIB perform
unique cellular functions. However, exactly how the cell regu-
lates IIA and IIB functions separately is not yet clear. Our data
support a role for ROCK in the preferential regulation of IIA-
RLC phosphorylation and are consistent with the strong corre-
lation observed between ROCK inhibition and IIA-depletion.
This raises the question as to how the cell specifically regulates
IIB activity. Themost obvious hypothesis is that one ormore of
the multiple other RLC kinases regulate IIB activity. Indeed,
Totsukawa et al. (23) demonstrated that myosin light chain
kinase and ROCK can regulate the phosphorylation of discrete
pools of RLC in different sub-cellular locales. Moreover,
although thrombin did not induce a significant change in heavy
chain phosphorylation on either isoform, epidermal growth
factor treatment has been shown to be important for regulating
IIB heavy chain phosphorylation and IIB activity (55, 56), rep-
resenting another mode of potential isoform specific regula-
tion. Regulation of IIA and IIB by distinct pathways is an attrac-
tive idea that could explain how myosin II performs its many
functions at different places in the cell at different times. Much
more work is required for a complete understanding of the
specific cellular roles of IIA and IIB, and how the activities of
these isoforms are distinctly regulated by the cell.
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